<DOC>
	<DOCNO>NCT02046291</DOCNO>
	<brief_summary>This single institution , phase I dose escalation study weekly romiplostim post umbilical cord blood transplantation patient fail achieve platelet engraftment day +30 . Engraftment define platelet count ≥ 20 x 109/L 3 consecutive measurement without transfusion 7 day . Romiplostim administer assign dose 6 weekly injection begin day +42 post transplant . Up 4 dose level ( 4 , 6 , 8 , 10 mcg/kg/dose ) evaluate maximum tolerate dose ( MTD ) romiplostim determine use Continual Reassessment Method ( CRM ) . The goal CRM identify 1 4 dose level corresponds desire maximum toxicity rate 20 % less .</brief_summary>
	<brief_title>Safety Romiplostim ( Nplate® ) Following UCBT</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Any patient undergone single double umbilical cord blood transplant ( UCBT ) except myelofibrosis . Those acute leukemia must remission time transplant No evidence recurrent disease bone marrow evaluation do within 14 day enrollment Must achieve neutrophil engraftment ( define ANC &gt; 500 three consecutive day ) daily GCSF prior start romiplostim . Intermittent GCSF allow . Failure achieve platelet engraftment ( defined platelet count ≥20x109/L 3 consecutive measurement without transfusion 7 day ) day +28 post UCBT Between day +28 day +42 status post myeloablative nonmyeloablative UCBT ( single double cord blood transplant ) Age ≥ 18 year Adequate organ function within 7 day enrollment define : Creatinine : ≤ 2.0 mg/dL Hepatic : SGOT SGPT &lt; 5 x upper limit institutional normal ( ULN ) Women child bear potential agree use effective contraception therapy 4 month completion therapy Voluntary write consent Known pregnancy Pregnancy Category C : adequate wellcontrolled study romiplostim pregnancy Known relapse acute leukemia myelodysplastic syndrome Presence bone marrow fibrosis bone marrow examination immediately prior UCBT Patients require one platelet transfusion per day History allergy romiplostim</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>umbilical cord transplant</keyword>
	<keyword>acute leukemia</keyword>
	<keyword>UCBT</keyword>
	<keyword>Hodgkin 's Lymphoma</keyword>
	<keyword>Lymphoid Leukemia</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Myeloid Monocytic Leukemia</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Hematopoietic malignancy</keyword>
</DOC>